Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary

O Mizuno1, U Ikeda, Y Hojo

  • 1Department of Cardiology, Jichi Medical School, Tochigi, Japan.

Cardiology
|June 26, 2001
PubMed

Insights

Tissue factor (TF) levels increase in coronary circulation after percutaneous transluminal coronary angioplasty (PTCA). Elevated TF 24 hours post-PTCA predicts late restenosis, indicating its prognostic value.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Interventional Cardiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for ischemic heart disease.
  • Restenosis remains a significant complication following PTCA.
  • Understanding the mechanisms of restenosis is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate changes in blood coagulation markers in the coronary circulation after PTCA.
  • To determine the clinical significance of these changes, particularly in relation to late restenosis.
  • To evaluate tissue factor (TF) as a potential prognostic marker for restenosis.

Main Methods:

  • Study included 43 patients with ischemic heart disease undergoing elective PTCA.
  • Blood samples collected from the coronary sinus pre-PTCA and at 4, 24 hours post-procedure.
  • Plasma levels of TF, thrombin-antithrombin III complex (TAT), and prothrombin fragment 1+2 (F 1+2) measured via ELISA.
  • Coronary angiography performed at 6 months to assess minimal luminal diameter and late loss index.

Main Results:

  • Significant increases in TF, TAT, and F 1+2 levels observed 24 hours after PTCA.
  • A positive correlation found between TF changes at 24 hours and the late loss index at 6 months.
  • Higher TF levels in coronary sinus blood were associated with late restenosis.

Conclusions:

  • Tissue factor expression in the coronary circulation increases post-PTCA.
  • Post-PTCA TF levels serve as a prognostic indicator for late restenosis.
  • Targeting TF may offer a strategy to mitigate restenosis after coronary interventions.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...